Literature DB >> 5333771

Uricosuric drugs, with special reference to probenecid and sulfinpyrazone.

A B Gutman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5333771     DOI： 10.1016/s1054-3589(08)60098-8

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 0568-0123


× No keyword cloud information.
  12 in total

1.  Is uric acid transported by the hippurate transport system?

Authors:  V D Jones; A Despopoulos
Journal:  Pflugers Arch       Date:  1974-06-11       Impact factor: 3.657

2.  [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat].

Authors:  J F Boudry
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

3.  Anti-inflammatory and related properties of 4-(p-biphenylyl)-3-hydroxybutyric acid.

Authors:  D I Barron; A R Copley; D K Vallance
Journal:  Br J Pharmacol Chemother       Date:  1968-06

Review 4.  Drug interferences with clinical laboratory tests.

Authors:  P P Sher
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

5.  The effect of tiaprofenic acid on uric acid excretion in man.

Authors:  L Sinigaglia; S Zeni; F Solazzi; G Di Minno; S Longatti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.

Authors:  G M Fanelli; I M Weiner
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03

Review 8.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

9.  Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Authors:  Sophie L Stocker; Kenneth M Williams; Andrew J McLachlan; Garry G Graham; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Effect of probenecid on phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes and granulocytes.

Authors:  H P Buisman; L F Buys; J A Langermans; P J van den Broek; R van Furth
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.